CELLASTRA INC

ENCODING SCAR-LESS HEALING  

 

 Targeting Unmet  Needs in COVID-19,

Aesthetic Surgery & Burn Care

CELLASTRA NEWS

CELLASTRA GENE THERAPY REPORT JANUARY 12,  2021

 __________________READ MORE       

 

CELLASTRA INC. 12/23/2020

 

Cellastra announces the appointment of Professor Sarah Wootton, PhD, as Member of Cellastra’s Scientific Advisory Board

San Francisco, CA, December 23, 2020, Cellastra, Inc., a developer of novel cell and gene therapy assets, announced today, that the company has appointed Professor Sarah Wootton, PhD, as new Member of Cellastra’s Scientific Advisory Board.

___________________     READ MORE     

 

CELLASTRA INC. 08/07/2020

Cellastra announces the appointment of  BIOTECanada veteran Brad Thompson, PhD, as Chairman of the Board and Ex Novartis veteran Vinod Kumar, MD, as Chief Medical Officer.  

                                          READ MORE

 

CELLASTRA INC 03/03/2020

Cellastra announces long-term results from in-vivo transgene expression of proprietary anti-scarring peptide

PrSan Francisco, CA, March 3, 2020  Cellastra, Inc., a developer of novel cell and gene therapy assets, announced today that the company has obtained promising results  for CELLEXA, a proprietary gene vector enabling in-vivo production of a potent anti-scarring peptide.

Cellastra recently reported results demonstrating that CELLEXA delivers the genetic code for the lactoferrin sub-peptide with the same amino acid sequence enabling expression during the first month of ovservation.

 “Our new results from long-term follow up demonstrates continued robust and durable transgenic expression and production of the peptide throughout the 11 week observation period  after intramuscular injection, and furthermore no adverse effects were noted” said Dr Karl Mettinger, MD, PhD, President & CEO of C

                                          READ MORE

02/19/2020

NEW GENE THERAPY INSTITUTE CREATE BY NIH

                                          READ MORE

388 Market St #1300, San Francisco, CA 94111, USA

©2018 by Cellastra Inc. Proudly created with Wix.com